INmune Bio FY 2025 Earnings Preview

* INmune Bio (INMB [https://seekingalpha.com/symbol/INMB]) is scheduled to announce FY earnings results on Monday, March 30th, after market close.
* The consensus EPS Estimate is -$0.27 [https://seekingalpha.com/symbol/INMB/earnings/estimates] (+87.2% Y/Y) and the consensus Revenue Estimate is $0.06M (+500.0% Y/Y).
* Over the last 3 months, EPS estimates have seen 0 upward revisions [https://seekingalpha.com/symbol/INMB/earnings/revisions] and 1 downward. Revenue estimates have seen 1 upward revision and 0 downward.

MORE ON INMUNE BIO

* INmune Bio Inc. (INMB) Discusses XPro1595 Phase II MINDFuL Results and Registrational Strategy in Alzheimer's Disease Transcript [https://seekingalpha.com/article/4876391-inmune-bio-inc-inmb-discusses-xpro1595-phase-ii-mindful-results-and-registrational-strategy]
* INmune Bio Inc. (INMB) Discusses MissionEB Phase III Trial and CORDStrom as a Disease-Modifying Therapy for RDEB Transcript [https://seekingalpha.com/article/4876040-inmune-bio-inc-inmb-discusses-missioneb-phase-iii-trial-and-cordstrom-as-a-disease-modifying]
* Seeking Alpha’s Quant Rating on INmune Bio [https://seekingalpha.com/symbol/INMB/ratings/quant-ratings]
* Historical earnings data for INmune Bio [https://seekingalpha.com/symbol/INMB/earnings]
* Financial information for INmune Bio [https://seekingalpha.com/symbol/INMB/income-statement]